Australia vs Middle East, North Africa, Afghanistan & Pakistan (excluding high income): Antiretroviral therapy coverage

Australia
88.0%
in 2023
Middle East, North Africa, Afghanistan & Pakistan (excluding high income)
26.5%
in 2024
Australia rank
23rd
Middle East, North Africa, Afghanistan & Pakistan (excluding high income) rank
22nd

Antiretroviral therapy coverage over time

  • Australia
  • Middle East, North Africa, Afghanistan & Pakistan (excluding high income)
020406080200020122024

How they compare

Australia currently reports 88.0% against 26.5% in Middle East, North Africa, Afghanistan & Pakistan (excluding high income), a difference of 61.5%.

That makes Australia's figure about 3.3 times Middle East, North Africa, Afghanistan & Pakistan (excluding high income)'s.

Across all 24 years both countries report, Australia has been ahead every year.

Australia ranks 23rd and Middle East, North Africa, Afghanistan & Pakistan (excluding high income) ranks 22nd of 143 countries.

Australia has averaged higher in every one of the 3 decades both report.

Head to head by decade

Decade Australia Middle East, North Africa, Afghanistan & Pakistan (excluding high income) Difference Ahead
2000s 53.9% 3.4% 50.5% Australia
2010s 75.5% 12.8% 62.7% Australia
2020s 86.0% 22.3% 63.7% Australia

Averages of every year both report within each decade.

Frequently asked questions

Which has higher antiretroviral therapy coverage, Australia or Middle East, North Africa, Afghanistan & Pakistan (excluding high income)?
Australia, at 88.0% against 26.5% in Middle East, North Africa, Afghanistan & Pakistan (excluding high income) as of 2023.
What is the difference in antiretroviral therapy coverage between Australia and Middle East, North Africa, Afghanistan & Pakistan (excluding high income)?
61.5%, with Australia ahead.
How many years of comparable data are there for Australia and Middle East, North Africa, Afghanistan & Pakistan (excluding high income)?
24 years are reported by both, from 2000 to 2023.
How do Australia and Middle East, North Africa, Afghanistan & Pakistan (excluding high income) rank globally for antiretroviral therapy coverage?
Australia ranks 23rd and Middle East, North Africa, Afghanistan & Pakistan (excluding high income) ranks 22nd of 143 countries.
Where does this data come from?
UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage (% of people living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Australia vs Middle East, North Africa, Afghanistan & Pakistan (excluding high income): Antiretroviral therapy coverage. Statizoid, drawing on UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Retrieved 19 September 2026, from https://health.statizoid.com/compare/antiretroviral-therapy-coverage-percent-of-people-living-with-hiv/australia/middle-east-north-africa-afghanistan-and-pakistan-excluding-high-income/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://health.statizoid.com/compare/antiretroviral-therapy-coverage-percent-of-people-living-with-hiv/australia/middle-east-north-africa-afghanistan-and-pakistan-excluding-high-income/">Australia vs Middle East, North Africa, Afghanistan & Pakistan (excluding high income): Antiretroviral therapy coverage</a> — Statizoid

About this data

Indicator
Antiretroviral therapy coverage (% of people living with HIV)
Unit
% of people living with HIV
Source
UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS)
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
166 places, 4,061 data points, 2000–2024
Last refreshed

Antiretroviral therapy coverage indicates the percentage of all people living with HIV who are receiving antiretroviral therapy.